Cargando…

COVID-19 vaccination and risk of neuralgic amyotrophy

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226591/
http://dx.doi.org/10.1007/s40278-022-17704-4
_version_ 1784733939400704000
collection PubMed
description
format Online
Article
Text
id pubmed-9226591
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-92265912022-06-24 COVID-19 vaccination and risk of neuralgic amyotrophy Reactions Weekly News Item Springer International Publishing 2022-06-25 2022 /pmc/articles/PMC9226591/ http://dx.doi.org/10.1007/s40278-022-17704-4 Text en © Springer International Publishing AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
COVID-19 vaccination and risk of neuralgic amyotrophy
title COVID-19 vaccination and risk of neuralgic amyotrophy
title_full COVID-19 vaccination and risk of neuralgic amyotrophy
title_fullStr COVID-19 vaccination and risk of neuralgic amyotrophy
title_full_unstemmed COVID-19 vaccination and risk of neuralgic amyotrophy
title_short COVID-19 vaccination and risk of neuralgic amyotrophy
title_sort covid-19 vaccination and risk of neuralgic amyotrophy
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226591/
http://dx.doi.org/10.1007/s40278-022-17704-4